You can’t do the research on mosunetuzumab, Fecal microbiota, live - jslm, and teclistamab, which are the new drugs are important targets for the observational research.
I understand that postprocessing instead of logic of incorporated into staging process has some risk of errors. But what errors will you get? errors with these reused concepts. Now they don’t work at all. So you can’t do it worse:)
Anyway, let’s discuss offline how I can help.